The various options for the treatment of retrograde ejaculation (RE) and anejaculation (AE) are discussed systematically in this review. A total of 88 studies dealing with patients with RE emphasize medical treatment for reversal of RE and retrieval of spermatozoa from urine. In 136 studies concerning patients with AE, the main emphasis is on medical treatment, electroejaculation (EE) and electrovibration stimulation (EVS) for the reversal of AE. Sperm quality in patients with RE and AE is often impaired. However, with the help of assisted reproduction techniques (ART) available today, both ejaculation disorders can be considered as treatable diseases. The major problem when analysing the studies was the uneven methodological quality of the original articles and the difficulties presented by different drugs and dosages, equipment and techniques, along with different criteria for success. In conclusion, controlled clinical trials comparing different treatment options appear urgently warranted.
Introduction
For physiological ejaculation, afferent stimuli travel, via the pudendal nerve, from the glans penis to the brain. Efferent response from sympathetic motor neurones emerges in segments T12 (11)-L3, passes through the inferior mesenteric ganglion, and forms the hypogastric nerve. The preganglionic fibres synapse with short postganglionic fibres in ganglia on the prostate, seminal vesicles and vas deferens. Antegrade ejaculation can be divided into three successive events (Hershlag et al., 1991) : (i) stimulation of the sympathetic nerves produces emission of semen from the ampulla of the vas deferens into the posterior urethra; (ii) sympathetic contraction of the posterior urethra and closure of the bladder neck; and (iii) parasympathetically (originating from S2 to S4) induced contraction of the bulbocavernosus and ischiocavernosus muscles and pelvic floor activity leading to antegrade ejaculation through the urethral meatus.
Anejaculation (AE) is defined as the total failure of seminal emission into the posterior urethra. Retrograde ejaculation (RE) is the substantial propulsion of seminal fluid from the posterior urethra into the bladder, and can appear as either complete RE (no antegrade fraction) or incomplete RE (only minimal antegrade emission). Diagnostic clues to AE are the complete absence of an antegrade ejaculation combined with a non-viscous, fructose-negative and sperm-negative postorgasmic urinalysis (Murphy and Lipshultz, 1987) . Diagnostic clues to RE include absent or intermittent emission of ejaculate, orgasm without ejaculation, an ability to empty the bladder during erection, and the presence of spermatozoa and fructose in post-coital specimens of urine.
In the absence of antegrade ejaculation, RE is the most common cause for ejaculatory dysfunction, and accounts for 0.3-2% of male infertility (Vernon et al., 1988; Yavetz et al., 1994) . Among the various reasons for AE and RE (Table I) , transurethral prostatectomy (TURP) or transurethral incision for benign prostatic hyperplasia (BPH) most commonly leads to RE in ≈75% of patients (Yavetz et al., 1994) . However, as BPH is mainly a disease of the ageing male, the most common reason for RE (and to a lesser extent also for AE) in patients consulting for infertility is retroperitoneal lymph node dissection (RLND) for the treatment of testicular cancer. After bilateral RLND, 60-94% of men complain of a loss of antegrade ejaculation by the removal or damage to the sympathetic ganglia and hypogastric plexus (Nijman et al., 1987) . However, modified unilateral RLND, as performed today, reduces the initial loss of antegrade ejaculation to 10-15% (Donohue et al., 1993) . Another group of patients affected by ejaculatory dysfunction (mostly AE) during their reproductive phase (average age at injury <30 years; Young et al., 1984) are men with spinal cord injury (SCI). Although erections after SCI were reported in 63% of 2461 patients, ejaculations were reported in only 14% of these patients and only 1.8% were able to achieve a pregnancy with their spouse (Otani et al., 1986) . Diabetes mellitus can also cause RE and AE, although less often than it leads to erectile dysfunction (Hershlag et al., 1991) . When, apart from organic reasons, no cause can be identified for ejaculatory dysfunction, it is classified as idiopathic or psychogenic (Köhn and Schill, 1994; Chung et al., 1998) ejaculatory dysfunction. Differential diagnosis of men with RE and AE includes retarded ejaculation and primary anorgasmia.
Various treatments have been proposed for the treatment of infertility related to AE or RE. However, uncertainty about the potential benefits or risks of individual treatment options exists. Thirty reviews have addressed this topic (Zeitlin et al., 1957; Bors and Comarr, 1960; Rowan et al., 1962; Comarr, 1970; Vogt, 1971; Tarabulcy, 1972; Griffith et al., 1973; Schirren et al., 1973; Lipshultz et al., 1981; Amelar and Dubin, 1982; Schröder and Krause, 1982; Thomas, 1983; Comarr and Downey, 1985; Murphy and Lipshultz, 1987; Ver Voort, 1987a,b; Shaban et al., 1988; Wein and Van Arsdalen, 1988; Bennett et al., 1990; Yarkony, 1990; Hershlag et al., 1991; Linsenmeyer and Perkash, 1991; Drawz and Drawz, 1992; Sonksen and Biering-Sorensen, 1992; Beckerman et al., 1993; Ohl, 1993; Sprouse, 1994a ,b, Yavetz et al., 1994 Chung et al., 1995) . However, since these reviews new options (e.g. intracytoplasmic sperm injection, ICSI) relevant to severe male infertility have been implemented, some of which apply to the treatment of ejaculatory disorders. Only one review concentrates on the effectiveness of electrovibration therapy of anejaculatory men and uses a systematic approach (Beckerman et al., 1993) . To evaluate the current status of infertility treatment related to AE or RE, a systematic approach was chosen to find answers to the following questions: (i) how many men with AE/RE can produce antegrade ejaculation following medical intervention, and what are the pregnancy rates?; (ii) what is the quality of semen produced by medical reversal of AE/RE?; (iii) what is the quality of semen in the urine specimens if no reversal of RE is attempted or failed (RE); (iv) what is the quality of semen in the urine specimens if only RE could be achieved in reversal of AE; and (v) what are the spontaneous or ART pregnancy rates (fertilization rates) in patients with retrograde ejaculation or AE? 
Literature search and analysis

Patients
The current review focuses solely on men with RE or AE who were treated for reversal of the ejaculatory disorders, or who underwent treatment of the accompanying infertility in a homologous system. Treatments of ejaculatory disorders involving donor insemination or oocyte-donating procedures in the spouse were not included. In addition, patients with obstructions of the efferent ducts or congenital absence of the vas deferens were not included.
Searching the literature and selecting relevant and valid studies
Articles were eligible for this review if they met the following inclusion criteria: 1. Intervention: The study had to deal with medical intervention related to fertility in patients with AE or RE. 2. Study design: As a preliminary search revealed only one randomized controlled clinical trial in the field, all controlled, uncontrolled and observational studies including individual case reports were included in the analysis.
3. Language: All English and German language papers were included.
Articles were identified by Medline research using the search strategy: 'retrograde ejaculation AND treat* OR therap*'. Of the 191 Medline hits dealing with RE, 46 original articles and review articles were classified as relevant according to the criteria outlined above. In addition, 42 articles dealing with RE could be identified by checking the references in articles examined, leading to 88 relevant articles in total. Using the search strategy 'anejaculation OR asperm* NOT retrograde', 72 Medline hits dealing with AE could be identified. Of these 72 articles, 28 original and review articles were classified as relevant, and additional 104 articles could be identified by checking the references in articles examined, leading to 132 relevant articles in total.
In addition, studies were excluded from the analysis if they analysed data that were also analysed by another study in the review as indicated by: (i) Statements of the authors; (ii) overlapping years of study conductance; (iii) unreasonably high numbers of study patients shortly after a previous publication with considerably lower numbers; and (iv) identical data in the papers.
In cases of suspicious data overlap, data from the later study were considered for the review. Only data from the first publication which were not presented in the second paper were evaluated.
Extracting the data
Following the only systematic review in the field (Beckerman et al., 1993) , the quality of the literature retrieved was graded using the following criteria: 1. Form and delivery of intervention: (i) Method of stimulation/drug (group, name, dose, duration); and (ii) apparatus. 2. Characteristics of study population: (i) Underlying diagnosis leading to AE/RE. 3. Sample size. 4. Study design. 5. Results of relevant outcome measures: (i) Response (antegrade/RE)/No response; (ii) semen volume (ml); (iii) sperm count (×10 6 /ml)/total sperm count (×10 6 ); (iv) sperm motility (%); (v) fertility outcome; (vi) characteristics of responders and non-responders; and (vii) side effects.
Statistics
Differences between proportions of ejaculatory response to medical intervention and pregnancy rates were tested by χ 2 test with Yates' correction for continuity.
Diagnoses and effects of treatment
In total, 342 patients with RE and 2346 patients with AE were reported in the 220 relevant articles obtained. The underlying reasons for their ejaculatory disorders are shown in Tables II  and III . 
Medical treatment
Medical treatment for the correction of RE is based either on increasing sympathetic tone of the bladder, or on decreasing parasympathetic activity, and was conducted with alphaagonistic or anticholinergic and antihistaminic drugs, mostly with imipramine (Tofranil  , Novartis; Pryleugan  , Temmler Pharma), milodrin (Gutron  , Nycomed), chlorpheniramine + phenylpropanalamine (Ornade  , SmithKline Beecham) or brompheniramine (Diametane  , Robins). At the given doses, side effects of drugs given for the reversal of RE include various degrees of dizziness, sleep disturbances, weakness, restlessness, dry mouth, nausea or sweating during the medical treatment, and occur frequently in responding patients. Tables IV-XIV. Unless indicated otherwise, values for ejaculate volume, sperm concentration, sperm motility are means. Numbers of patients are given as total numbers; success rates of treatment are given as total numbers and percentages (in parentheses). Pelvic OP = pelvic operation; RLND = retroperitoneal lymph node dissection; TURP = transurethral prostatectomy.
Success rates and ejaculate parameters are presented in Table  IV . One study (Nijman et al., 1987) was excluded from the analysis as no data regarding the success of the imipramine treatment were given. Regarding the reversal of RE, no differences (P = 0.4; power = 0.6) between the medical treatments could be detected. No differences (P = 0.6; power = 0.4) could be detected between the response rates of the underlying diagnosis [bladder neck insufficiency 20%, diabetes mellitus 31%, idiopathic RE 78%, RLND 53%, urethral stricture 67%, SCI 50%, others (aortic surgery, thiodazine, pelvic surgery, sphincter hypertrophy) 39%, unclear diagnosis 47%] and the response to medical treatment.
All studies reporting spontaneous (Table Va) or ART pregnancies (Table Vb) as an outcome parameter or reporting on pregnancies in their study population were included in the analysis. One study (Nijman et al., 1982) was excluded from the analysis as the later publication (Nijman et al., 1987) covered the previous study period. With respect to low power (0.4), no differences (P = 0.3) between the spontaneous pregnancy rates and the medical drug used could be detected. Due to the low numbers and low corresponding power (0.17), no advantage of ICSI treatment over intrauterine insemination (IUI) treatment (P = 0.3) could be detected.
Drug therapy for the reversal of AE was conducted mostly with alpha-agonistic drugs [imipramine, ephedrine (Ephedral; Wolff) , pseudoephedrine (Sudafid; Burroughs Wellcome)] or with parasympathomimetic (acetylcholinesterase antagonists) drugs [physostigmine (Anticholim  ; Köhler), neostigmine (Prostigmin  ; ICN)]. At the given doses, serious side effects of parasympathomimetic drugs include the potential for severe autonomic dysreflexia in men with lesions above T6 (Linsenmeyer and Perkash, 1991) . Therefore, neostigmine was abandoned because of its severe side effects including headaches, sweating and vomiting. There was one reported death of a man with C6 to C7 quadriplegia from a cerebral haemorrhage after using neostigmine (Guttmann and Walsh, 1971) . In contrast to neostigmine (intrathecal administration), physostigmine can traverse the blood-brain barrier and can be administered subcutaneously. This not only simplifies the treatment but also decreases the incidence of severe side effects. However, it was reported to cause parasympathetic side effects of nausea, vomiting, abdominal cramps and diarrhoea, as well as orthostatic hypotension for 1 h after ejaculation. Pretreatment with N-butylhyoscine bromide (Buscopan  ; Boehringer Ingelheim), an inhibitor of the peripheral parasympathetic system, or metoclopramide (Paspertin  ; Solvay) or atropine (Atropin sulfat Braun, 100 mg Injektionslsg  ; Braun) at 10-30 min before medication with parasympathetic drug decreases its peripheral adverse events while permitting the central action of physostigmine, and should therefore be recommended (Jesionowska and Hemmings, 1991) . Tables IV-XIV. Numbers of patients, pregnancies and cycles are given as totals; if indicated, pregnancy rates per patients are given also as percentages (in parentheses). ICSI = intracytoplasmic sperm injection; IUI = intrauterine insemination; IVF = in-vitro fertilization; RLND = retroperitoneal lymph node dissection. Tables IV-XIV. Numbers of patients are given as totals; success rates of treatment are given as total numbers and percentages (in parentheses). BHB = N-butylhyoscine bromide; EVS = electrovibration stimulation; Met = metoclopramide; RLND = retroperitoneal lymph node dissection; SCI = spinal cord injury.
Success rates and ejaculate parameters of patients with medical treatment of AE are presented in Table VI . One study (Ohl et al., 1991) was excluded from the analysis as no data regarding the success of the alpha-agonist therapy were provided. Regarding the reversal of AE, no differences (P = 0.1) between the alpha-agonistic medical treatments could be detected (power = 0.7). However, the alpha-agonistic drugs were significantly inferior (P < 0.001, power = 0.9) than treatment with parasympathetic drugs, while there were no differences (P = 0.4; power = 0.1) between the parasympathetic drugs. No differences (P = 0.2; power = 0.5) could be detected between the response rates to alpha-agonists between the different diagnoses (SCI 0%, RLND 17%, idiopathic AE 0%, diabetes mellitus 1%, other diagnosis 5%). In addition, among SCI patients treated with parasympathetic drugs there was no difference (P = 0.6; power = 0.1) in response to medical treatment between patients with lesions including T11 and above (175 patients/88 responders) and those with lesions below T11 (30 patients/18 responders).
Semen parameters of anejaculatory patients are given in only the following studies: Blockmans and Steeno, 1988; 2.2 ml ejaculate volume, 105×10 6 /ml, 20% total motility; Jesionowska and Hemmings, 1991; 1.6-4 ml ejaculate volume, 186×10 6 /ml, 40% total motility; Jonas et al., 1979; 6.2×10 6 total; 2% total motility; Piera, 1973; 4.5 ml ejaculate volume, 0.12×10 6 /ml, 18% total motility; Schill, 1990; 1.4-4.2 ml ejaculate volume, 138-412×10 6 /ml, 30-40% total motility; and Spira, 1956 ; 182.5×10 6 /ml, 19% total motility. Spontaneous pregnancies with the use of alpha-agonists in anejaculatory patients were reported in two cases (Goldwasser et al., 1983; Schill, 1990 ) out of eight (Kelly and Needle, 1979; Stewart and Ohl, 1989; Köhn and Schill, 1994) evaluated. From patients receiving parasympathetic drugs, six spontaneous pregnancies and nine pregnancies by auto-IUI (in which the couple performs the insemination) were reported (Chapelle et al., 1988) . In addition, from 20 patients a total of seven pregnancies could be induced by artificial IUI (Spira, 1956; Guttmann and Walsh, 1971; Chapelle et al., 1976; Schill, 1982; Otani et al., 1986; Blockmans and Steeno, 1988; Jesionowska and Hemmings, 1991) .
Electrovibration stimulation
Electrovibration stimulation (EVS) initiates reflex spinal cord activity, causing ejaculation. The patient is seated upright in a chair, or is placed in a supine position. To induce ejaculation, the vibrator is applied to the penile surface, or to the lower surface of the glans penis. The frequency of the vibrators ranged from 60 to 120 Hz, whereas the peak-to-peak amplitude of excursion ranged from 1.5 to 4.5 mm. Every stimulation cycle should be carried out for 3 min or until antegrade ejaculation occurs. Every cycle should be followed by a rest period of 2 min and should be terminated when no further ejaculate can be obtained, or when a maximum of approximately six stimulation cycles is completed. In general, the duration of stimulation lies between 10 s and 18 min. Criteria for discontinuation of the procedure were blood pressure exceeding 200 mmHg systolic or 130 mmHg diastolic, or reported headache and signs of autonomic dysreflexia. For prevention of autonomic dysreflexia in SCI patients, nifedipine or prazosin should be given in all patients with lesions above T6. Some studies additionally perform pre-and post-vibration catheterization of the bladder with instillation of a buffer medium into the bladder for better sperm recovery in case of RE.
In two studies (Sobero et al., 1965; Schellen, 1968) , EVS was applied in patients with idiopathic RE. In 12 out of 14 patients, ejaculation occurred after between 1 and 12 min. Nine pregnancies after EVS (six after auto-IUI, three after IUI) were reported in patients with RE. Tables IV-XIV. Numbers of patients are given as totals; success rates of treatment are given as total numbers and percentages (in parentheses). CCT = controlled clinical trial.
Success rates and ejaculate parameters of patients with EVS therapy of AE are presented in Table VII . Two studies Ohl et al., 1997) were excluded from the analysis as no data regarding the success of the EVS therapy were provided. Three other studies (Brindley, 1981b; Brackett et al., 1995 Brackett et al., , 1997 were excluded as their data were also presented in later studies (Brindley, 1984; Brackett et al., 1998) . No differences (P = 0.3; power = 0.2) could be detected between the total response rates towards EVS therapy between anejaculatory patients due to SCI or idiopathic AE. However, the proportion of patients with antegrade ejaculation after EVS was significantly (P < 0.003, power = 0.9) higher in idiopathic AE compared with SCI-dependent AE. In the studies giving the level of the lesion, patients with lesions including T11 and above (366 patients/262 responders) had a significantly higher response to EVS (P = 0.003, power = 0.9) than patients with lesions below T11 (93 patients/33 responders). Altogether, 143 pregnancies (see Table VIII ) have been reported following ART after EVS in anejaculatory men. No differences in success rates were identified between the different ART in patients with SCI (P = 0.2; power = 0.5). Tables IV-XIV. Numbers of patients are given as totals; success rates of treatment are given as total numbers and percentages (in parentheses). IVF and GIFT were evaluated together. EE = electroejaculation; ICSI = intracytoplasmic sperm injection; IUI = intrauterine insemination; IVF = in-vitro fertilization; GIFT = gamete intrafallopian transfer.
Transrectal electroejaculation
Electroejaculation (EE) stimulates nerves responsible for ejaculation. The patient is positioned in the right lateral decubitus position on a table, with his thighs and knees slightly flexed. Blood pressure is measured continuously until the procedure is completed. Digital rectal examination and anoscopy is performed before and after the procedure to evaluate the rectal mucosa. The rectal stimulator is stabilized against the anterior wall at the level of the seminal vesicles, and electrostimulation is started. Electrical current should be delivered in a progressively increasing wave-like pattern until ejaculation occurs, which normally requires 1-7 min of stimulation. The sine wave voltage ranged from 16 to 22 V at 200-500 mA. During the procedure, the pendulous and bulbar urethra is continuously milked to collect the ejaculate.
Side effects of EE include rectal mucosa injury and transitory erythema, thermal-electrical injury to the rectum, the risk of autonomic dysreflexia with paroxysmal hypertension, and vomiting. Pretreatment with 10-30 mg nifedipine reduces the side effects of autonomic dysreflexia. EE can cause significant discomfort in men with incomplete injuries and pinprick sensations in the sacral or L4 or L5 dermatome, and unpredictable intolerance in those with intact sensation in the L1 to L3 dermatome (Brindley, 1981a) . All men except those with SCI require general anaesthesia for EE. Criteria for discontinuation of the procedure are signs of autonomic dysreflexia, or if the rectal temperature reaches 40°C. As in EVS, pre-and post-stimulation catheterization of the bladder with instillation of a buffer medium into the bladder lead to better sperm recovery in cases of RE.
In one study (Rosenlund et al., 1998) , EE was applied in six patients with RE due to RLND. All patients responded to EE, and two and one pregnancies occurred after IVF (three cycles) and ICSI (three cycles) respectively.
Success rates and ejaculate parameters of patients with EE therapy of AE are presented in Table IX . Nine studies (Rawicki and Lording, 1988; Randolph et al., 1990; Steinberger et al., 1990; Denil et al., 1992; Toledo et al., 1992; McLachlan et al., 1995; Tucker et al., 1995; Ohl et al., 1997; Hovav et al., 1998) were excluded from the analysis as no data regarding the success of the EE therapy were provided; three other studies were completely (Brindley, 1980; Bennett et al., 1987a,b) and three partially (Brindley, 1981a; Brackett et al., 1995; Chung et al., 1996) excluded as their data were also presented in later studies (Brindley, 1984; Bennett et al., 1988; Bennett and Ohl, 1989; Brackett et al., 1997 , Chung et al., 1997 .
No differences (P = 0.72; power = 0.17) could be detected between the total response rates to EE between anejaculatory patients due to SCI or idiopathic AE, diabetes mellitus or RLND. The overall ejaculatory response rate of EE with solid bars was superior (P = 0.04; power 0.6) compared with finger cot electrodes. In the studies where the level of the lesion is presented, no difference (P = 0.2; power = 0.9) between patients with lesions including T11 and above (461 patients/365 responders) and patients with lesions below T11 (112 patients/68 responders) could be detected.
Altogether, 170 pregnancies (see Table X ) following ART after EE in anejaculatory men have been reported. Three studies (Rawicki and Lording, 1988; Toledo et al., 1992; Chung et al., 1996) were excluded from the analysis as their data were also presented in later studies (Rawicki and Hill, 1991; Tucker et al., 1995; Chung et al., 1997) . Between the different ART in patients with SCI, IVF/gamete intrafallopian transfer (GIFT) (P = 0.02; power = 0.8) and ICSI (P = 0.03; power = 0.7) were significantly more effective per cycle than the different IUI procedures which were equally effective (P = 0.4; power = 0.2). No difference (P = 0.4, power = 0.1) could be detected between the success rate of ICSI and IVF/GIFT cycles. In patients with AE due to RLND after EE, IVF/GIFT (P < 0.001, power = 0.99) and ICSI (P = 0.05, power = 0.9) were significantly more effective per cycle than the different IUI procedures which were equally effective (P = 0.2, power = 0.2). No difference (P = 0.8 power = 0.1) could be detected between the success rate of ICSI and IVF/GIFT cycles. No differences could be observed in success rate per cycle between the different ART in patients with idiopathic AE (P = 0.1; power = 0.46). When comparing IUI (P = 0.4; power = 0.37), IVF/GIFT (P = 0.22; power = 0.31) and ICSI (P = 0.4; power = 0.2) success per cycle, no difference between SCI, RLND and idiopathic anejaculatory patients could be observed.
Surgical techniques
Surgical procedures for patients with RE aiming for the restitution of normal ejaculation are the Abrahams technique (Abrahams et al., 1975) and the Young-Dees operation (Dees, 1949) . All other surgical techniques which could be used in patients with RE or AE in whom spermatozoa could not be obtained otherwise, aimed solely at sperm recovery, e.g. microsurgical vas deferens aspiration (Berger et al., 1986) , Brindley reservoir (Brindley et al., 1986) , Wagenknecht alloplastic spermatocele (Löchner-Ernst et al., 1997) and recovery of epididymal or testicular spermatozoa (MESA/TESE) (Rosenlund et al., 1998) for ART.
Two studies (Abrahams et al., 1975; Ramadan and el-Demiry, 1985) reported the use of the Abrahams technique for reversal of RE in four patients with a history of bladder neck surgery. The procedure was successful in two patients, one of whom subsequently fathered a child (Abrahams et al., 1975) . Two studies (Ramadan and el-Demiry, 1985; Middleton and Urry, 1986 ) applied the Young-Dees operation in 10 patients (two of whom previously had been unsuccessfully operated on with the Abrahams technique) with a history of bladder neck surgery. The procedure was successful in eight patients, and two patients induced five pregnancies in their spouses .
Success rates and ejaculate parameters of RE or AE patients with surgical sperm retrieval are presented in Table XI . As spermatozoa could be recovered in all patients but one, no difference in the total response rates to surgical sperm retrieval between anejaculatory patients could be detected. In total, 32 pregnancies (see Table XII ) after surgical sperm retrieval in anejaculatory men with ART have been reported. As for the Brindley reservoir, artificial cycle numbers are not given in some studies, so no statistical analysis was performed. For the microsurgical vas deferens sperm retrievals no differences (P = 0.5, power 0.2) in success rates per cycle between the different artificial methods could be observed. a Study numbers for cross-referencing in Tables IV-XIV. Numbers of patients are given as totals; success rates of treatment are given as total numbers and percentages (in parentheses). CCT = controlled clinical trial; EVS = electrovibration stimulation; prog. = progressive.
Sperm retrieval from the urine
Urine is known to have a detrimental effect on sperm quality, and sperm motility may decrease by at least half within 5 min of mixing with urine (Crich and Jequier, 1978) . Therefore, most studies aiming for retrieval of the retrograde ejaculate from the bladder induce alkalization of the urine pH with NaHCO 3 (dose 1.2-16 g) given orally for a duration of a few hours up to 3 days to adjust urinary pH to 7-8 before masturbation. However, in addition to the detrimental effect of urine pH, there is evidence that osmolarity should be the major concern, and studies showed that decreased sperm motility was more closely related to reduced osmolarity rather than to pH (Crich and Jequier, 1978; Linsenmeyer et al., 1989) . In order to reduce osmotic stress to spermatozoa, some studies either install buffered media into the bladder before ejaculation, or try to manipulate the osmolarity of the urine via the fluid intake of the patient, in addition to pH adjustment. Studies of interventions performed in RE patients with sperm retrieval from the bladder in which ejaculate parameters are given are presented in Table XIII . A total of 94 pregnancies (see Table  XIV ) fathered by men with RE after ART have been reported. The pregnancy rates per IUI cycle between alkalization of urine, instillation of medium, alkalization of urine plus instillation of medium, and no intervention before RE were not significantly different (P = 0.2; power = 0.5). The IVF and ICSI pregnancy rates per cycle between alkalization and medium instillation were also not different (P = 0.4; power = 0.1).
Other approaches
In one patient with idiopathic RE (Crich and Jequier, 1978) , one with congenital RE (Crich and Jequier, 1978) and one with RE due to diabetes mellitus (Templeton and Mortimer, 1982) , antegrade ejaculation and subsequently three pregnancies after a total of seven IUI cycles were achieved if the patient ejaculated in a standing position with full bladder. Another technique leading to antegrade ejaculation in a RE patient due to transurethral prostatectomy (TURP) was the tamponade of the bladder neck with the balloon of a Foley catheter during masturbation. The resulting ejaculate was successfully used for IUI and a pregnancy could be achieved after eight IUI cycles (Liukko and Nikkanen, 1979) . Five further spontaneous pregnancies could be induced by four patients with congenital RE and post-bladder neck surgery with post-coital voiding into the vagina either with (Marmar et al., 1977) or without (Schram, 1976) prior alkalization of urine.
In eight of 11 patients with idiopathic AE due to psychological disturbances, antegrade ejaculation was reported after psychological therapy (Geboes et al., 1975) . If the AE is due to androgen deficiency, androgens or gonadotrophin substitution leads to normal ejaculation (Schellen, 1968) .
Interpretation of results
The major problem when analysing studies in patients with AE or RE being treated for fertility disturbances is the often unsatisfactory methodological quality of the original articles (Beckerman et al., 1993) . Despite various treatment modalities for these patients, only four controlled clinical trials could be identified. As treatment effectiveness in the field of infertility can be judged fairly only in controlled clinical trials (Kamischke and Nieschlag, 1998) , evidence provided by case reports and observational studies is weak, and caution is advised when comparing the results of different types of drugs and electrostimulation procedures. Furthermore, a considerable publication bias in the papers is apparent, as pregnancy rates per patient (e.g. up to 100% in Table XIV ) with ART are conspicuously high compared with other fields of male infertility. Tables IV-XIV. Numbers of patients, pregnancies and cycles are given as total numbers; if indicated, pregnancy rates per patients are given also as percentages (in parentheses) IVF and GIFT were evaluated together EVS = electrovibration stimulation; ICSI = intracytoplasmic sperm injection; IUI = intrauterine insemination; IVF = in-vitro fertilization; GIFT = gamete intrafallopian transfer; RLND = retroperitoneal lymph node dissection; SCI = spinal cord injury. a Study numbers for cross-referencing in Tables IV-XIV. Numbers of patients are given as total numbers; success rates of treatment are given as total numbers and percentages (in parentheses). RLND = retroperitoneal lymph node dissection; TURP = transurethral prostatectomy. Tables IV-XIV. Numbers of patients, pregnancies and cycles are given as total numbers; if indicated, pregnancy rates per patients are given also as percentages (in parentheses). IVF and GIFT were evaluated together. EE = electroejaculation; EVS = electrovibration stimulation; ICSI = intracytoplasmic sperm injection; IUI = intrauterine insemination; IVF = in-vitro fertilization; GIFT = gamete intrafallopian transfer; OP = operation; RLND = retroperitoneal lymph node dissection; SCI = spinal cord injury; TESE = testicular sperm extraction; TURP = transurethral prostatectomy.
A further difficulty in analysing the results is that most studies used different drugs and dosages, equipment and techniques, and applied different criteria for success. The description of the results was not always complete, so in many instances critical information was not available for comparison. Nonetheless, under consideration of the methodological quality of the studies some general conclusions can be drawn.
Treatment of RE
Most patients with RE wish to conceive offspring naturally. However, apart from the four patients who voided post-coitally into the vagina of their spouse (Marmar et al., 1977) and the 10 patients who had been operated with the Abrahams or Young-Dees technique (Abrahams et al., 1975; Middleton and Urry, 1986) , spontaneous pregnancies were only reported in patients with medical treatment of RE. As the underlying diagnosis seems to have no major influence on the overall 50% success rate of medical treatment, this treatment modality of RE has to be considered the first choice. Although not significantly different from the other drugs, 50 mg/day (given orally) of the commercially distributed combination (Ornade ; SmithKline Beecham) of chlorpheniramine + phenylpropanalamine (79% success rate, n = 14 patients), 25-75 mg/ day oral imipramine (64% success rate, n = 110 patients), and 5-40 mg iv milodrin (56% success rate, n = 27 patients) seems to offer the best treatments (see Table IV ), especially with respect to spontaneous and ART pregnancy rates (see Table Va Tables IV-XIV. Numbers of patients are given as totals; success rates of treatment are given as total numbers and percentages (in parentheses). OP = operation; prog. = progressive; RLND = retroperitoneal lymph node dissection; SCI = spinal cord injury; TURP = transurethral prostatectomy. Tables IV-XIV. Numbers of patients, pregnancies and cycles are given as total numbers; if indicated, pregnancy rates per patients are given also as percentages (in parentheses). IVF and GIFT were evaluated together. IUI = intrauterine insemination; IVF = in-vitro fertilization; GIFT = gamete intrafallopian transfer; SCI = spinal cord injury; TURP = transurethral prostatectomy.
If medical treatment of RE fails, the next choices include the use of EVS and sperm recovery from the urine, because EE requiring general anaesthesia and surgical sperm retrieval are not indicated in most patients (see Table II ). To avoid the detrimental effect of urine on sperm quality, EVS offers the possibility to achieve antegrade ejaculation. However, only two studies (Sobero et al., 1965; Schellen, 1968) , involving a total of 14 patients, have applied this approach. Although pregnancy rates with auto-IUI and IUI were promising, effectiveness should be confirmed in larger clinical trials. Sperm recovery from the bladder should be the second approach to retrieve spermatozoa for artificial procedures in men with RE.
As urinary pH and osmolarity are important for sperm quality, alkalization of the urinary pH with NaHCO 3 (dose 1.2-16 g orally) given a few hours and up to 3 days before ejaculation should be performed. Osmolarity of the urine can be manipulated via fluid intake. Medium instillation seems to offer no benefit over non-invasive procedures. Most studies have performed inseminations with spermatozoa recovered from urine. However, as ICSI has been shown to be superior to other ART in cases of severe male infertility, it should be considered as first choice if only spermatozoa of poor quality could be retrieved. As so far no benefit of ICSI compared with IUI or IVF could be observed (probably due to the low number of patients treated with ICSI), this consideration should be confirmed in controlled clinical trials. In the absence of such a study, the choice of whether to perform IUI, IVF or ICSI could be made on the basis of the sperm criteria, as in the case when applying ART to ejaculated semen with disturbed characteristics.
If no viable spermatozoa can be retrieved by other methods, EE and surgical sperm retrieval should be considered as the last resort. However, only a few patients with RE have been treated with EE (n = 6; three pregnancies), vas deferens aspiration (n = 1, no pregnancy) or TESE (n = 1, one pregnancy) so far, and therefore success rates are difficult to predict.
Treatment of AE
As in patients with RE, medical treatment offers AE patients the only chance to conceive naturally. However, only a few patients treated with alpha-agonist (n = 2) or physostigmine (n = 6), have been reported to achieve this goal. One reason for this disappointing result is the generally low (19%) overall success rate of the alpha-agonists (Table VI) . Only 5-30 mg i.v. milodrin (54% overall success) seems to have a considerable effect on restoration of ejaculation in patients with AE due to RLND. Whether milodrin can also restore ejaculation in patients with other causes of AE remains unclear. Although the parasympathomimetics are significantly better (51% overall success) than the alpha-agonists, they suffer from potentially severe side effects and, with one exception (Chapelle et al., 1988) , have only been applied in a clinical setting. Because of severe side effects and its invasive application (intrathecally), neostigmine has to be considered obsolete, and physostigmine (1-2 mg subcutaneous) should only be applied after pretreatment with 20-40 mg butylhyoscine bromide and under careful monitoring of signs of autonomic dysreflexia (Linsenmeyer and Perkash, 1991) in SCI patients. In addition, parasympathomimetics have been successfully used only in men with SCI, and their usefulness in other causes of AE is unclear. All in all, in contrast to RE, medical treatment of AE cannot be recommended generally as treatment of first choice and warrants further investigation.
Although no spontaneous pregnancies could be achieved, EVS together with auto-IUI offers the couple the possibility of achieving a pregnancy in the privacy of their home (66 pregnancies total; see Table VIII ). Evidence from controlled clinical trials indicates that spermatozoa obtained with vibratory stimulation were of better quality and had the marked advantage of patient acceptance compared with EE. Therefore, penile vibratory stimulation should be attempted first to induce ejaculation in SCI patients (Brackett et al., 1997; Ohl et al., 1997) . In addition, pregnancy rates in ART seem to be higher in patients treated with EVS (Table VIII) compared with EE (Table X) . However, here too, SCI patients with lesions above T6 should be treated with caution to prevent autonomic dysreflexia, for which pretreatment with nifedipine or prazosin and careful monitoring should be performed.
The overall success rates between anejaculatory patients with SCI and idiopathic AE did not differ. The rate of RE was higher in SCI patients, which might be explained by the higher rate of additional bladder neck surgery in SCI patients compared with idiopathic AE. Prognostic factors for overall success of EVS therapy include the amplitude of the vibrator and the height of the lesion in SCI patients. Controlled clinical trials indicate that high amplitude is superior (≥2.5 mm) to low amplitude (Sonksen et al., 1994; Brackett et al., 1998) . In addition, there was a significantly higher success rate in patients, including T11 and above, compared with patients with lesions below T11 (Table VII) . The presence or absence of reflex hip flexion on scratching the soles of the feet and the duration of injury <6 months before EVS seems to have no major prognostic relevance for EVS, as ejaculates could also be obtained in a considerable number of patients with absence of reflex hip flexion and surgery less than 6 months prior (Sonksen et al., 1994) . Whether repeated vibratory ejaculation treatment improves semen quality in SCI men who have not ejaculated earlier after injury remains controversial.
Most studies have performed inseminations with the spermatozoa obtained. However also here, in light of the advantage of IVF/ICSI over IUI in other fields of infertility, IVF/ICSI should be considered as first choice, if only spermatozoa of poor quality can be retrieved (Dahlberg et al., 1995) .
As EE has a higher success rate in inducing ejaculation, it can be used when penile vibratory stimulation is not successful, and in ten studies (see Table IX ) it was possible to retrieve spermatozoa with EE after EVS failure. As in SCI patients treated with EVS, SCI patients with lesions above T6 have a risk of developing autonomic dysreflexia, and therefore pretreatment with nifedipine or prazosin and careful monitoring of signs of autonomic dysreflexia and injury of the rectum are also necessary in these cases. In addition, SCI men with unpredictable tolerance-and all non-SCI patients, require general anaesthesia.
The underlying diagnosis of AE has no influence on the overall success rate of EE. Electroejaculation with solid bar electrodes appears more effective compared with finger cot electrodes. Other factors seem to have no major influence on success prognosis. In agreement with others (Brindley, 1981a; Lucas et al., 1991) , we find that no physical finding, e.g. the height of the lesion, the degree of completeness of the spinal cord injury, or a duration of injury of less than 6 months can (with certainty) predict the success rate of EE. As stasis of semen may play a role in decreased sperm motility, repeated EE may improve semen quality after two to four treatments (Brindley, 1984; Halstead et al., 1987; Ohl et al., 1989a; Linsenmeyer and Perkash, 1991; Lim et al., 1994) .
Most studies have performed inseminations with the spermatozoa obtained with EE (Table XI) . However, as the number of studies using IVF and ICSI was considerably greater than those using EVS and medical treatment, the pregnancy rates per cycle with IVF and ICSI in anejaculatory patients treated with EE were significantly greater compared with IUI. Therefore, IVF and ICSI is the treatment of choice in patients with poor sperm quality after EE. No differences of the success rates of ART could be detected between the different diagnoses.
If no viable spermatozoa can be retrieved with the other treatment modalities, surgical sperm retrieval together with IVF and ICSI provides a good alternative for anejaculatory men (Hovatta and von Smitten, 1993; Löchner-Ernst et al., 1997) . Although spermatozoa could be retrieved in eight of nine cases, the long-term results of the alloplastic spermatocele (see Wagenknecht et al., 1978) were generally disappointing because of early fibrosis of the channel between epididymis and spermatocele and subsequent low pregnancy rates (Löchner-Ernst et al., 1997) . Most studies have applied the relatively easy, microsurgical vas deferens aspiration to retrieve spermatozoa in anejaculatory patients. However, only a limited number of punctures can be performed, although sperm cryopreservation creates further opportunities for additional ART cycles. Pregnancy rates comparable with microsurgical vas deferens aspiration, and the advantage of puncturing the inguinal vas deferens sperm reservoir subcutaneously repeatedly without affecting the epididymis (Brindley et al., 1986) , clearly offers an advantage over other surgical approaches. However, a reduction of sperm quality in the punctuate 5-6 months after implantation and infections at the implantation site give cause for concern (Löchner-Ernst et al., 1997) . If no spermatozoa can be aspirated at the vas deferens or epididymis, TESE in combination with ICSI offers the last possibility for treatment.
Concern has also been raised regarding a higher miscarriage rate in patients with RE and AE. However, analysing all studies which present pregnancy outcome in their data, the miscarriage rates were 14% for auto-IUI/IUI, 23% for IVF/GIFT, and 12% for ICSI in men with AE or RE. This is comparable with the general population in which the total rate of pregnancy loss after implantation, including clinically recognized spontaneous abortions, was 31% (Wilcox et al., 1988) .
Conclusions
In parallel with the rise in artificial fertilization techniques, various options for the treatment of RE and AE have been developed and successfully applied. Although sperm quality in patients with RE and AE is often impaired, nowadays both ejaculation disorders have to be considered as treatable diseases. However, most studies are only case reports and observational cohort studies, and it remains questionable which treatment modality offers the best chances for these patients. Controlled clinical trials comparing different treatment options are urgently needed to identify the best treatment option for patients with RE and AE.
